En pacientes previamente tratados con metformina y/o sulfonilureas la adicin de por lo menos 3 aos con GLP1-RA, evidencindose una mejora de marcadores lipdicos como triacilglicridos (-12%), colesterol total (-5%), LDL (-6%) y HDL (+24%) 149
Consult a healthcare provider for guidance on combining supplements
Two AM, et al
For pharma and biotech IP teams, R&D executives, and institutional investors, the practical imperatives follow from this analysis
Compared with other neuropsychiatric illnesses, most studies on the effects of GLP-1RAs in psychotic disorders seem to have focused so far on their potential use to counteract the cardiometabolic side effects due to antipsychotic medications
Oral small-molecule GLP-1 agonists provide chemically defined structures that integrate more effectively into molecular docking, dynamic simulation, and quantitative structureactivity relationship models compared with flexible peptide ligands